MEDIGUS LTD's ticker is MDGSW and the CUSIP is 58471G128. A total of 7 filers reported holding MEDIGUS LTD in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $5,057 | +100.0% | 85,714 | -0.0% | 0.00% | – |
| Q1 2023 | $2,529 | -80.3% | 85,715 | +0.0% | 0.00% | – |
| Q4 2022 | $12,857 | -90.0% | 85,714 | -93.3% | 0.00% | -100.0% |
| Q3 2022 | $129,000 | -59.4% | 1,285,715 | 0.0% | 0.00% | -66.7% |
| Q2 2022 | $318,000 | -17.6% | 1,285,715 | 0.0% | 0.01% | -14.3% |
| Q1 2022 | $386,000 | +43.0% | 1,285,715 | 0.0% | 0.01% | +75.0% |
| Q4 2021 | $270,000 | -63.8% | 1,285,715 | 0.0% | 0.00% | -69.2% |
| Q3 2021 | $745,000 | +3.5% | 1,285,715 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $720,000 | -34.9% | 1,285,715 | 0.0% | 0.01% | -48.0% |
| Q1 2021 | $1,106,000 | +1.0% | 1,285,715 | 0.0% | 0.02% | -32.4% |
| Q4 2020 | $1,095,000 | +72.7% | 1,285,715 | 0.0% | 0.04% | +60.9% |
| Q3 2020 | $634,000 | -58.6% | 1,285,715 | 0.0% | 0.02% | -76.3% |
| Q2 2019 | $1,533,000 | -24.9% | 1,285,715 | 0.0% | 0.10% | -13.4% |
| Q1 2019 | $2,040,000 | +16.6% | 1,285,715 | 0.0% | 0.11% | -15.8% |
| Q4 2018 | $1,749,000 | – | 1,285,715 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CVI Holdings, LLC | 55,486 | $2,347 | 0.00% |
| Skaana Management L.P. | 67,920 | $2,309 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| Citadel Advisors | 11,946 | $505 | 0.00% |
| ARMISTICE CAPITAL, LLC | 85,714 | $5,057 | 0.00% |
| JPMORGAN CHASE & CO | 478 | $28 | 0.00% |
| UBS Group AG | 2,855 | $97 | 0.00% |